[TREATMENT OF CHOLESTASIS]

Area of Science:

• Hepatology
• Gastroenterology
• Internal Medicine

Background:

• Cholestasis encompasses diverse etiologies, including intrahepatic and extrahepatic conditions.
• The precise cellular mechanisms underlying cholestasis remain incompletely elucidated.
• Understanding cholestasis is crucial for managing various liver diseases.

Purpose of the Study:

• To provide an overview of cholestasis, covering its causes, diagnosis, and treatment.
• To highlight key diagnostic modalities and therapeutic strategies for intrahepatic cholestasis.
• To discuss established treatments for primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC).

Main Methods:

• Review of existing literature on cholestasis.
• Analysis of diagnostic approaches including history, physical examination, laboratory tests, serology, and ERCP.
• Evaluation of current treatment strategies for cholestasis, focusing on PBC and PSC.

Main Results:

• Cholestasis presents with varied causes, necessitating differentiation between intrahepatic and extrahepatic origins.
• Diagnosis relies on a combination of clinical evaluation and specific investigations.
• Established treatments for PBC and PSC include ursodeoxycholic acid and immunosuppressants, with liver transplantation as a vital option.

Conclusions:

• Effective management of cholestasis requires accurate diagnosis and cause-specific treatment.
• Current therapeutic options for leading intrahepatic cholestatic disorders are defined, but further research into cellular mechanisms is warranted.
• Liver transplantation remains a critical intervention for advanced cholestatic liver disease.